Abstract:BACKGROUND: Computed tomography-derived fractional flow reserve (CT-FFR) using on-site machine learning enables identification of both the presence of coronary artery disease and vessel-specific ischemia. However, it is unclear whether on-site CT-FFR improves clinical or economic outcomes when compared with the standard of care in patients with stable coronary artery disease. METHODS: In total, 1216 patients with stable coronary artery disease and an intermediate stenosis of 30% to 90% on coronary computed tomographic angiography were randomized to an on-site CT-FFR care pathway using machine learning or to standard care in 6 Chinese medical centers. The primary end point was the proportion of patients undergoing invasive coronary angiography without obstructive coronary artery disease or with obstructive disease who did not undergo intervention within 90 days. Secondary end points included major adverse cardiovascular events, quality of life, symptoms of angina, and medical expenditure at 1 year. RESULTS: Baseline characteristics were similar in both groups, with 72.4% (881/1216) having either typical or atypical anginal symptoms. A total of 421 of 608 patients (69.2%) in the CT-FFR care group and 483 of 608 patients (79.4%) in the standard care group underwent invasive coronary angiography. Compared with standard care, the proportion of patients undergoing invasive coronary angiography without obstructive coronary artery disease or with obstructive disease not undergoing intervention was significantly reduced in the CT-FFR care group (28.3% [119/421] versus 46.2% [223/483]; P < 0.001). Overall, more patients underwent revascularization in the CT-FFR care group than in the standard care group (49.7% [302/608] versus 42.8% [260/608]; P=0.02), but major adverse cardiovascular events at 1 year did not differ (hazard ratio, 0.88 [95% CI, 0.59-1.30]). Quality of life and symptoms improved similarly during follow-up in both groups, and there was a trend towards lower costs in the CT-FFR care group (difference, -Upsilon 4233 [95% CI, -Upsilon 8165 to Upsilon 973]; P=0.07). CONCLUSIONS: On-site CT-FFR using machine learning reduced the proportion of patients with stable coronary artery disease undergoing invasive coronary angiography without obstructive disease or requiring intervention within 90 days, but increased revascularization overall without improving symptoms or quality of life, or reducing major adverse cardiovascular events.

GW26-e0741 Fractional Flow Reserve Guided Percutaneous Coronary Intervention improves clinical outcome with reduced cost in Chinese real world practice

Fractional Flow Reserve Guided Percutaneous Coronary Intervention improves clinical outcome with reduced cost in Chinese real world practice

Fractional Flow Reserve Guided Percutaneous Coronary Intervention Improves Clinical Outcome with Reduced Cost in Contemporary Clinical Practice

Application of intraaortic balloon counterpulsation during primary percutaneous coronary intervention in patients with cardiogenic shock complicating with acute myocardial infarction

Fractional Flow Reserve or Intravascular Ultrasound for PCI.

Intra‐aortic Balloon Pump on In‐hospital Outcomes of Cardiogenic Shock: Findings from a Nationwide Registry, China

Radiofrequency Ablation Using the ThermoCool SmartTouch Catheter Guided by Ablation Index Versus Antiarrhythmic Drugs in Atrial Fibrillation Treatment in China: a Cost-Consequence Analysis.

On-Site Computed Tomography-Derived Fractional Flow Reserve to Guide Management of Patients With Stable Coronary Artery Disease: The TARGET Randomized Trial

GW27-e0365 A Meta-analysis of the Efficacy and Safety of Adjunctive Intra-Aortic Balloon Pump in Patients with Acute Myocardial Infarction

Clinical Effectiveness of Automated Coronary CT-derived Fractional Flow Reserve: A Chinese Randomized Controlled Trial

Two-year results and subgroup analyses of the PEPCAD China in-stent restenosis trial: A prospective, multicenter, randomized trial for the treatment of drug-eluting stent in-stent restenosis.

Abstract 317: Costs and Benefits Associated with Transradial Percutaneous Coronary Intervention in China

GW25-e5222 Safety and Efficacy of a Novel Technique in the Use of Fractional Flow Reserve in Complex Coronary Artery Lesions

THE EFFICACY AND SECURITY ANALYSIS OF INTERVENTIONAL THERAPY SUPPORTED BY INTRA-AORTIC BALLOON PUMP FOR PATIENTS WITH HIGH RISK CORONARY HEART DISEASE

Preoperative prophylactic insertion of intraaortic balloon pumps in critically ill patients undergoing coronary artery bypass surgery: a meta-analysis of RCTS

Application of intra-aortic balloon pump in acute myocardial infarction complicared with cardiogenic shock undergoing percutaneous coronary intervention

Effects of intra-aortic balloon pump on in-hospital outcomes and 1-year mortality in patients with acute myocardial infarction complicated by cardiogenic shock

The Outcomes of Intra-Aortic Balloon Pump Usage in Patients with Acute Myocardial Infarction: a Comprehensive Meta-Analysis of 33 Clinical Trials and 18,889 Patients.

Evalu ation of intra aorticb alloon pump sa sisted percutaneous coronary intervention in patients with acute myocardial infarction and heart failure

Clinical evaluation of intra aortic balloon couterpulsation in percutaneous coronary interention for patients with acute myocardial infarction combined with cardiogenic shock

Prophylactic Intra-Aortic Balloon Pump Reduces C-Reactive Protein Levels And Early Mortality In High-Risk Patients Undergoing Percutaneous Coronary Intervention